Journal: Scientia Pharmaceutica
Article Title: Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)-[1,2,4]triazolo[1,5- c ]quinazolines
doi: 10.3797/scipharm.1211-08
Figure Lengend Snippet: The influence of compounds on the growth of individual tumor cell lines (GI 50 ≤1.00 μM)
Article Snippet: 3.20 , 30.8 , , −22.19–76.81 , 34.45 (A549/ATCC/nscLC), 47.80 (EKVX/nscLC), 31.79 (HOP-62/nscLC), −20.29 (HOP-92/nscLC), 53.15 (NCI-H226/nscLC), 56.08 (NCI-H23/nscLC), 49.63 (NCI-H322M/nscLC), 6.93 (NCI-H460/nscLC), 18.28 (NCI-H522/nscLC), 48.35 (COLO 205/ColC), 28.33 (HCT-116/ColC), 37.98 (HCT-15/ColC), 12.96 (HT29/ColC), 28.18 (KM12/ColC), 18.19 (SW-620/ColC), 52.47 (BT-549/BC), −8.25 (HS 578T/BC), 0.99 (MCF7/BC), 54.69 (MDA-MB-231/ATCC/BC), −8.47 (MDA-MB-435/BC), 66.42 (NCI/ADR-RES/BC), 50.41 (T-47D/BC), 43.70 (IGROV1/OV), 8.02 (OVCAR-3/OV), 52.75 (OVCAR-4/OV), 24.28 (OVCAR-8/OV), 59.20 (SK-OV-3/OV), 16.34 (CCRF-CEM/L), −22.19 (HL-60(TB)/L), 13.53 (K-562/L), 30.40 (MOLT-4/L), 24.50 (RPMI-8226/L), 6.80 (SR/L), 34.92 (786-0/RC), −8.58 (A498/RC), 39.91 (ACHN/RC), 28.32 (CAKI-1/RC), 15.38 (RXF 393/RC), 56.09 (SN12C/RC), 59.47 (TK-10/RC), 54.96 (UO-31/RC), 42.29 (LOX IMVI/M), 40.18 (M14/M), 18.32 (MALME-3M/M), 63.78 (SK-MEL-2/M), 59.92 (SK-M EL-28/M), −9.71 (SK-MEL-5/M), 33.49 (UACC-257/M), 49.90 (UACC-62/M), 40.89 (DU-145/PC), 44.69 (SF-268/CNSC), −21.73 (SF-295/CNSC), 16.51 (SF-539/CNSC), 44.03 (SNB-19/CNSC), 27.05 (SNB-75/CNSC),.
Techniques: